

Science
Eli Lilly Outpaces Novo Nordisk in the GLP-1 Weight Loss Drug Race
Eli Lilly is gaining a competitive edge over Novo Nordisk in the rapidly growing market for GLP-1 weight loss and...
Eli Lilly is gaining a competitive edge over Novo Nordisk in the rapidly growing market for GLP-1 weight loss and...
Eli Lilly’s groundbreaking weight loss drug, Zepbound, has demonstrated significant benefits in patients suffering from a common type of heart...